The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Reproductive Medicine Associates of New Jersey
- Study ID
- NCT06629766
- Status
- Recruiting
Conditions
- Infertility (IVF Patients)
- Oocyte Competence
- Paternal Age
- Sperm DNA Fragmentation
- Sperm Selection
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 41 Years
- Healthy Volunteers
- Not accepted
Interventions
- Microfluidic sperm separation device — DEVICEAn aliquot of 850ul will be used for the Zymot sperm selection device. The sperm processing via Zymot will be per manufacturer's guidelines
- Density grade centrifugation — OTHER5ul of the ejaculated sample will be assessed for DGC via Makler assessment. If the sample for DGC is adequate per lab standard operating procedures, then routine DGC sperm preparation and embryologist sperm selection for the ICSI procedure will occur.
Study Details
This study aims to assess the effect of age of the male partner and the reproductive ability of sperm prepared via sperm selection devices (Zymot) compared to routine embryologist selected sperm after density gradient centrifugation (DGC) preparation for intracytoplasmic sperm injection (ICSI) in patients undergoing in vitro fertilization treatment (IVF) of their infertility.
Key Dates
- Start date
- Apr 9, 2025
- Status verified
- Jun 2026
- Primary completion
- Jan 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Oocytes inseminated by sperm prepared by a microfluidic (Zymot) sperm preparation deviceHalf of the mature oocytes will be randomly allocated to receive sperm prepared by the microfluidic (Zymot) sperm preparation device. This sperm will be used by the embryologist for the ICSI procedure.
- Other: Oocytes inseminated by sperm prepared via density grade centrifugationThe other half of the mature oocytes will be allocated to receive sperm prepared by DGC. This sperm will be used by the embryologist for the ICSI procedure.
Primary Outcome Measure
Blastulation Rate per Mature Oocyte (M2) [ Time Frame: approximately 1 week post oocyte retrieval procedure ]
Central Contacts
- Caroline Clinical Research Nurse, BSN, RN973-656-2841
- Christine Director of Research Operations, MS, BSN, RN973-656-2841
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Reproductive Medicine Associates of New Jersey | Basking Ridge | New Jersey | 07920 | - |
Find similar trials in Basking Ridge, NJ
Related Studies
- Quantifying Uterine Elastography in Menstruating WomenRecruiting · Reproductive Medicine Associates of New Jersey · Basking Ridge, New Jersey
- Male Infertility and Assisted Reproductive Technologies Research BiobankRecruiting · Reproductive Medicine Associates of New Jersey · Basking Ridge, New Jersey
- Language Matters: Exploring the Impact of Language Concordance on Fertility Treatment ProgressionRecruiting · Washington University School of Medicine · St Louis, Missouri
- Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few EmbryosPHASE3 · Recruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts